Schneid Yair 13D and 13G filings for Galera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-16 10:26 am Unchanged |
2024-04-16 | 13G | Galera Therapeutics, Inc. GRTX |
Schneid Yair | 10,823,610 19.900% |
0 (Unchanged) |
Filing |
| 2024-05-01 5:01 pm Purchase |
2024-04-19 | 13G | Galera Therapeutics, Inc. GRTX |
Schneid Yair | 10,823,610 19.900% |
3,712,809 (+52.21%) |
Filing |
| 2024-01-16 6:09 pm Purchase |
2024-01-05 | 13G | Galera Therapeutics, Inc. GRTX |
Schneid Yair | 7,110,801 13.073% |
7,110,801 (New Position) |
Filing |